Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Female genital warts: global trends and treatments Gall SAInfect Dis Obstet Gynecol 2001[]; 9 (3): 149-54The increasing incidence of human papillomavirus (HPV) infection and HPV-associated conditions such as genital warts in women is a global concern. Genital warts are a clinical manifestation of HPV types 6 and 11, and are estimated to affect 1% of sexually active adults aged between 15 and 49. HPV infection is also strongly associated with cervical cancer, and is prevalent in as many as 99% of cases. The psychological stress of having genital warts is often greater than the morbidity of the disease, and therefore successful treatment is crucial. Current treatments are patient-applied and provider-administered therapies. Imiquimod 5% cream, a patient-applied therapy, is an efficacious treatment with tolerable side-effects and a low recurrence rate, and has the potential to be an effective strategy for the management of genital warts.|Adjuvants, Immunologic/*therapeutic use[MESH]|Aminoquinolines/*therapeutic use[MESH]|Condylomata Acuminata/complications/*epidemiology/psychology/therapy[MESH]|Female[MESH]|Global Health[MESH]|Health Knowledge, Attitudes, Practice[MESH]|Humans[MESH]|Imiquimod[MESH]|Incidence[MESH]|Papillomavirus Infections/drug therapy/epidemiology/prevention & control[MESH]|Prevalence[MESH]|Risk Factors[MESH]|Treatment Outcome[MESH]|Uterine Cervical Neoplasms/etiology[MESH] |